Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers

Part of paid clinical trials in Aurora, Colorado.

Sponsor
University of Colorado, Denver
Study ID
NCT00900419
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
21 Years - 90 Years
Healthy Volunteers
Not accepted

Interventions

  • immunohistochemistry staining method — OTHER
    Laboratory test
  • laboratory biomarker analysis — OTHER
    Laboratory Test
  • sputum cytology — OTHER
    Laboratory Test
  • biopsy — PROCEDURE
    Laboratory Test

Study Details

RATIONALE: Studying samples of sputum and tissue in the laboratory from patients with dysplasia or cancer may help doctors identify and learn more about biomarkers related to cancer. It may also help the study of cancer in the future. PURPOSE: This laboratory study is looking at biomarkers in patients with respiratory tract dysplasia or lung cancer, head and neck cancer, or aerodigestive tract cancer.

Key Dates

Start date
May 3, 2001
Status verified
Sep 2025
Primary completion
Sep 30, 2027
Completion
Sep 30, 2027

Study Design

Enrollment
700 participants (estimated)

Primary Outcome Measure

Genetic mutations or altered growth factor expression [ Time Frame: After study has completed ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Colorado Cancer Center at UC Health Sciences CenterAuroraColorado80045
Clinical Trials Office - University of Colorado Cancer Center
303-724-1657

Find similar trials in Aurora, CO

By condition
Esophageal cancerHead and neck cancerLung cancer
By specialty
OncologyGI oncologyENTLung oncologyLung disease
By research site
University of Colorado Cancer Center at UC Health Sciences Center· Aurora, CO

Related Studies